PharmTech Talk

Jan 10, 2018
Will Alex Azar’s experience in the pharmaceutical industry help or hurt the initiative to keep medications affordable?
Dec 20, 2017
New tax legislation may result in savings for biopharma companies.
Dec 07, 2017
An increasing number of warning letters shows that FDA is observing more problems with pharmaceutical contract manufacturing.
Nov 30, 2017
Experts slam drug prices and endorse government price negotiations and curbs on drug advertising.
Nov 27, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
Manufacturers and trading partners struggle to meet drug tracking requirements
Nov 07, 2017
By Pharmaceutical Technology Editors
While most pharma companies are in partial production using generators, few are operating at 100% capacity.
Nov 07, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
The debate continues over biosimilar naming, interchangeability, and patent protection, as well as lingering concerns in the medical community about the safety of switching patients to new therapies.
Oct 05, 2017
FDA and manufacturers strive to prevent drug shortages from Hurricane Maria.
Sep 25, 2017
Biopharmaceutical companies developing new competitive biotech therapies have pressed hard for clarity on the testing and data required by FDA to gain market approval of biosimilars that can be filled by a pharmacist without prescriber preapproval.
Aug 28, 2017
High-priority issues requiring immediate attention leave little time for Congress to consider drug access proposals that have limited bipartisan support.
lorem ipsum